Catiil, Armando, NONE. D.
HRN: 12-67-50 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/02/2023
MUPIROCIN 2%, 15G (TUBE)
06/02/2023
06/09/2023
TOPICAL
Apply To Affected Area
Q8H
DM FOOT
Waiting Final Action
Indication: Empiric Then Culture-directed Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes